腫瘍学における免疫プロファイリング:技術と治療のギャップを埋める
Nanthini Ravi1, Gee Jun Tye1,2, Satvinder Singh Dhaliwal1,3,4
1Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, Minden, 11800, Penang, Malaysia.
Medical oncology (Northwood, London, England)
|August 26, 2025
まとめ
CyTOFやscRNA-seqのような 進化した免疫プロファイリング技術は 腫瘍の免疫相互作用を 精密医療で明らかにすることで 腫瘍学に革命をもたらしています AIを統合することで 癌の診断と治療の戦略をさらに改善できます
科学分野:
- 腫瘍学
- 免疫学
- バイオ情報学
背景:
- 免疫プロファイリングは 腫瘍と免疫の相互作用を理解し 精密腫瘍学の進歩に不可欠です
- 最近の技術革新は,免疫異質性の特徴と治療反応の予測を大幅に改善しました.
研究 の 目的:
- 腫瘍学における免疫プロファイリング技術の進化と統合をレビューする.
- 臨床的意思決定のためのマルチオミックスのデータを分析する上で人工知能 (AI) の役割について議論する.
- がん治療の免疫プロファイルの課題と将来の方向性を特定する.
主な方法:
- 質量サイトメトリ (CyTOF)
- 単細胞RNAシーケンシング (scRNA-seq)
- 空間トランスクリプトミクス
- 液体生検
- 人工知能 (AI) によるマルチオミックスの統合
主要な成果:
- 免疫不均一性の特徴と治療反応の予測の強化
- 新しいバイオマーカー,治療標的,および抵抗メカニズムを特定する.
- 人工知能モデルは 予測的洞察を通して 研究と臨床のギャップを埋めています
結論:
- 免疫プロファイリング技術は 癌の診断,治療の選択,モニタリングに 変化をもたらしています
- 先進的な技術,バイオインフォマティクス,臨床フレームワークの統合により パーソナライズされたデータベースのがん治療が可能になります
- 費用,スループット,標準化の課題に対処することは,より広範な臨床採用の鍵です.
関連する概念動画
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K


